EUCTR2012-003169-16-NL进行中（未招募）不适用
Immune monitoring to characterize T-cell responses of kidney transplant patients during co-stimulation blockade by belatacept
Erasmus MC, University Medical Center Rotterdam0 个研究点开始时间: 2012年8月23日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •a) Male or female kidney transplant recipients.
- •b) Age = 18 years.
- •c) Patients receiving a first or second kidney allograft.
- •d) Patients receiving a kidney allograft from a living donor.
- •e) Patients receiving a bloodgroup AB0-compatible kidney allograft.
- •f) Patients receiving a non-HLA identical kidney transplant.
- •g) PRA <30%
- •h) Patients must have known EBV serostatus, and that status must be positive.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 20
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 20
排除标准
- •a) Recipients of a third (or higher) allograft
- •b) Recipients of a non-renal organ transplant
- •c) Recipients of a kidney transplant from a deceased donor
- •d) Recipients under the age of 18 years
- •e) Sensitized transplant recipients (defined as a PRA of =30%)
- •f) Recipients of a HLA-identical kidney allograft
- •g) Recipients of a bloodgroup AB0-incompatible kidney allograft
- •h) Recipients with a historically positive cross-match
- •i) Patients with a history of lymphoma
- •j) Seronegative or unknown EBV serostatus
- •k) Patients with tuberculosis who have not been treated for latent infection.
- •l) Patients at high risk for polyoma virus-associated nephropathy, which is mostly due to BK virus infection.
研究者
相似试验
已完成
4 期
Immune monitoring to characterize T-cell responses of kidney transplant patients during co-stimulation blockade by belataceptKidney transplantation100276651002914910038365acute rejectionNL-OMON41595Erasmus MC, Universitair Medisch Centrum Rotterdam41
已完成
不适用
An initial study to determine the T lymphocyte response in seriously ill COVID-19 patients: An observational study in Pune, IndiaCTRI/2021/03/032028Dr D Y Patil Vidyapeeth Pune137
尚未招募
不适用
Post vaccination immunological response and immune monitoring for SARS-CoV-2CTRI/2021/08/035338Medanta Institute of Education and Research
已完成
不适用
Cellular & Serological Immune Response Monitoring in SARS-CoV2-infected individuals, without need of hospitalizatioCorona virusCOVID-191004743810024970NL-OMON50071eids Universitair Medisch Centrum10
已完成
不适用
A pilot study to characterize T cell responses in young children after influenza infectio10047438influenzaNL-OMON33577niversitair Medisch Centrum Utrecht125